Allan E. Inglis, Jr., MD

Dr. Inglis’s practice is dedicated to the surgical treatment of arthritic conditions in adults. He holds a special interest in total joint replacement of the hip, knee, and elbow, and is intimately involved in the custom design of joint replacements in the most difficult cases. He also has extensive experience and expertise in the surgical treatment of fractures of the pelvis and acetabulum, hip, femur (thigh bone), knee, and tibia (shin bone).

Born and raised in New York, Dr. Inglis graduated from Cornell Medical School and completed his internship at the Virginia Mason Hospital in Seattle. He then returned to New York where he completed his orthopaedic surgical training at Hospital for Special Surgery. While serving as Chief Resident at HSS, Dr. Inglis won the highly regarded Bowen-Brooks Fellowship for Postgraduate Research Abroad. He spent a year at the Institute of Orthopaedics at the Royal National Orthopaedic Hospital in London, England and completed his fellowship in Orthopaedic Biomechanics and Custom Prosthesis Design. During this time, Dr. Inglis also studied at the EndoKlinik in Hamburg, Germany, where he learned the latest techniques in the treatment of infection of total joint replacements.

Dr. Inglis later returned to the states, where he completed a second fellowship in Total Joint Replacement and Revision Total Joint Replacement at the world-renowned Kerlan-Jobe Orthopaedic Clinic, one of the original centers for non-cemented total joint and revision total joint replacement in the world. Dr. Inglis joins HSS’s Surgical Arthritis Service from Roosevelt and St. Luke's Hospital in New York City, where he was a senior attending orthopaedic surgeon.

Appointments

Specialty

Special Expertise

Procedures

Awards

Affiliations

Languages

Insurance Information

Industry Relationships

Industry Relationships

One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.

As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.

As of June 12, 2018, Dr. Inglis, Jr. reported no financial interest relationships with healthcare industry.

By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.